Prognostic markers in pancreatic ductal adenocarcinomas.
Deptartment of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.
Aram F
AF
Hezel
Nabeel
N
Bardeesy
D000230:Adenocarcinoma / Q000175:diagnosis / Q000378:metabolism / Q000473:pathology; D014408:Biomarkers, Tumor / Q000032:analysis*; D021441:Carcinoma, Pancreatic Ductal / Q000175:diagnosis* / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000378:metabolism / Q000473:pathology*; D011379:Prognosis; D051573:Proto-Oncogene Proteins c-pim-1 / Q000032:analysis*
D014408:Biomarkers, Tumor; C496634:PIM1 protein, human; D051573:Proto-Oncogene Proteins c-pim-1